However, the frequency of CD4+CD25+CD127low/− Tregs in CD4+ T cells of MS patients was significantly increased in co-cultures with UC-MSCs compared to those without UC-MSCs (Figure 1D, **p<0.01). This evidence concerns the gene CD4 and myeloid sarcoma.